Western Australia health authorities detected a vaccine-derived poliovirus strain in untreated wastewater at the Subiaco wastewater treatment plant in Perth [1].
The discovery marks a significant public health event because the virus had not been seen in the region for decades. While the risk to the general public is considered low, the presence of the virus in urban infrastructure indicates a potential breach in the country's polio-free status.
Officials said the strain is a vaccine-derived poliovirus [4]. This version of the virus is a weakened form originating from the oral vaccine. Health authorities said the presence of the strain is linked to a recent overseas arrival [1].
The timing of the detection is notable. Some reports indicate this is the first time this poliovirus strain has been detected in Australia in 54 years [1]. Other data suggests a fatal disease has not been detected in an Australian city's wastewater since 2000 [2], while further reports state the contagious disease had not been seen in the country for over 50 years [3].
Monitoring of wastewater is a critical tool for early detection of infectious diseases. By identifying the virus at the Subiaco plant, officials can track the spread of the pathogen without relying solely on clinical cases. This proactive surveillance allows health departments to ensure vaccination rates remain high among the population to prevent the virus from circulating.
Authorities said they continue to monitor wastewater levels to determine if the virus is spreading or if the detection was an isolated incident linked to a single traveler. The focus remains on maintaining high immunization coverage to protect the community from potential outbreaks.
“The strain is linked to a recent overseas arrival.”
The detection of vaccine-derived poliovirus in wastewater highlights the ongoing risk of virus importation in a globalized travel environment. Because this specific strain originates from the oral vaccine used in other countries, it underscores the necessity of maintaining high domestic vaccination rates to prevent 'silent' circulation in populations with immunity gaps.




